Is Diabetic Skeletal Fragility Associated with Microvascular Complications in Bone?

Roberto Jose Fajardo

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Purpose of Review: The objective of this literature review is to determine whether there are indications that microvascular complications occur in diabetic bone. Evidence definitively linking diabetic skeletal fragility with microvascular complications in bone remains elusive. Recent Findings: Circumstantial evidence, some recent and some lost to time, suggests that atherosclerotic vascular diseases such as peripheral arterial disease cause poor blood perfusion of bone and subsequent hypoxia and contribute to low bone density and high cortical porosity, patterns similar to some recently observed in diabetic subjects. Evidence also exists to suggest that potentially anti-angiogenic conditions, such as impaired vascular endothelial growth factor (VEGF) signaling, predominate in diabetic bone. Summary: Microvascular complications may contribute, in part, to diabetic skeletal fragility but data supporting this interpretation are primarily circumstantial at this time. This review highlights gaps in our knowledge and hopefully spurs further discussions and research on this topic.

Original languageEnglish (US)
JournalCurrent Osteoporosis Reports
Issue number1
StatePublished - Feb 1 2017


  • Atherosclerosis
  • Cortical porosity
  • Fracture risk
  • Type 2 diabetes
  • Vascular disease

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Is Diabetic Skeletal Fragility Associated with Microvascular Complications in Bone?'. Together they form a unique fingerprint.

Cite this